Angela Jain, MD

Angela Jain, MD
This physician is not currently rated. Why?

Why is this doctor not rated?


To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Clinical Locations

Assistant Professor, Department of Hematology/Oncology 
Interim Chief, Division of Breast Medical Oncology
Chief, Division of Gynecologic Medical Oncology

NCCN, Occult Primary Panel Member

NCCN Ovarian Cancer Panel Member

Key Awards

2023 top doctors
Medical Oncology

Educational Background

  • Fellow, Hematology/Oncology, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA, 2013
  • Resident, Internal Medicine, Temple University Hospital, Philadelphia, PA, 2010 
  • MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2007

Melanie Fowler

  • Breast Cancer

I’m 65 years old, and thanks to a 35-year career at the Department of Defense, I’ve been happily retired for just about a decade. I live in Willow Grove, Pennsylvania, with my husband Bill, our dog Tess, short for Tess the Mess, and our cat Amoco, who is named for the gas station where we found her.


Angela Shammo

  • Breast Cancer

I was a first grade teacher for six years before becoming a reading specialist for kids with learning disabilities. After having four children of my own, I decided to be a stay-at-home mom and teach my children, along with my nieces and nephews.


Selected Publications

Armstrong D.K., Alvarez R.D., Bakkum-Gamez J.N., Barroilhet L., Behbakht K., Berchuck A., Chen L.M., Cristea M., DeRosa M., Eisenhauer E.L., Gershenson D.M., Gray H.J., Grisham R., Hakam A., Jain A., Karam A., Konecny G.E., Leath C.A., Liu J., Mahdi H., Martin L., Matei D., McHale M., McLean K., Miller D.S., O'Malley D.M., Percac-Lima S., Ratner E., Remmenga S.W., Vargas R., Werner T.L., Zsiros E., Burns J.L.,Engh A.M., Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 19(2): 191-226, 2021.

Jain, A et al. “Metastatic Mucinous Ovarian Cancer and Treatment Decisions Based on Histology and Molecular Markers rather than the Primary Location” JNCCN September 2012. PubMed

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...